Tariffs have been a defining feature of US trade policy under President Donald Trump’s second administration. Since Trump unveiled his “reciprocal” tariff policy in April 2025, the landscape has shifted repeatedly.In February 2026, the US Supreme Court invalidated tariffs imposed…
Kanako Kikuchi, president of GlaxoSmithKline K.K., the Japan arm of GlaxoSmithKline PLC, will step down at the end of this year, only nine months after she took office in April as the local unit’s first Japanese president. According to a…
To read the full story
Related Article
- Former GSK Japan Chief Kanako Kikuchi Named UCB Japan President
April 19, 2018
- GSK Canada Head Tapped for Japan President
January 10, 2018
- GSK Poised to Re-Enter Japan Oncology Space with Novel Myeloma Drug
December 6, 2017
- Kanako Kikuchi to Become Japan Chief of GSK
March 7, 2017
BUSINESS
- Vital KSK’s Medleap Pivots to In-House Drug Filings, Eyes 2029 Launch
November 10, 2026
- Alfresa, Partners Seal Share Deal to Formalize Biosimilar JV
November 10, 2026
- Japan Ethical Drug Sales Rise 3.5% in September: Crecon
November 10, 2026
- Shionogi Grabs Japan Nod for Updated COVID Vaccine
November 10, 2026
- Kyorin Nabs Japan Rights to Edesa’s ARDS Drug
November 10, 2026





